Hypothesizing dopaminergic genetic antecedents in schizophrenia and substance seeking behavior

Keyphrases

• Schizophrenia 100%
• Substance Use Disorder 100%
• Seeking Behavior 100%
• Schizophrenic Patients 83%
• β-endorphin 33%
• Dopamine D2 Receptor (DRD2) 33%
• DRD2 Gene 33%
• Taq1 33%
• A1 Allele 33%
• Reward Deficiency Syndrome 33%
• Neuroimaging 16%
• Meta-analysis 16%
• Alcohol 16%
• Dopamine 16%
• Nucleus Accumbens 16%
• Polymorphism 16%
• Genome-wide Association Study 16%
• Epigenetics 16%
• Addiction 16%
• Drugs of Abuse 16%
• Alcoholism 16%
• Neurogenetics 16%
• Psychosis 16%
• Systems Biology 16%
• Alcohol Seeking 16%
• Dopamine System 16%
• Psychiatric Illness 16%
• Genetic Risk 16%
• Dopaminergic Activity 16%
• Reward Function 16%
• Gamma Type 16%
• Protective Agents 16%
• A2 Allele 16%
• Alcohol-seeking Behavior 16%
• Self-healing Mechanism 16%

Neuroscience

• Behavior (Neuroscience) 100%
• Dopaminergic 100%
• Endorphin 50%
• Nucleus Accumbens 50%
• Gamma-Endorphin 50%
• Meta-Analysis 50%
• Dopaminergic Activity 50%
• Dopamine Receptor D2 50%
• Genome-Wide Association Study 50%

Medicine and Dentistry

• Substance Use Disorder 100%
• Allele 50%
• Addictive Behavior 16%
• Alcoholic Polyneuropathy 16%
• Genome Wide Association Study 16%
• Nucleus Accumbens 16%
• Meta-Analysis 16%
• Self-Healing 16%
• Genetic Risk 16%
• Dopaminergic Activity 16%
• Protective Agent 16%
• Dopamine Receptor D2 16%
• Gamma Endorphin 16%
• Endorphin 16%